# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-331139
Filing Date
2025-12-23
Accepted
2025-12-23 17:15:04
Documents
4
Period of Report
2025-12-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | itrm-20251223.htm | PRE 14A | 1660863
2 | GRAPHIC | img189820637_0.jpg | GRAPHIC | 3845
3 | GRAPHIC | img189820637_1.jpg | GRAPHIC | 622855
4 | GRAPHIC | img189820637_2.jpg | GRAPHIC | 225990
| Complete submission text file | 0001193125-25-331139.txt |  | 2836232

Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38503 | Film No.: 251601697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)